Association of cytomegalovirus (CMV)-specific CD4+ T lymphocyte reactivity and protective immunity against acquired immunodeficiency syndrome-related CMV retinitis

Jacobson M.A.Bredt B.M.SUNG-CHING PANSZU-MIN HSIEH2020-12-292020-12-2920020022-1899https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036891028&doi=10.1086%2f345369&partnerID=40&md5=8550b61ad010de26914e1a93edfd3ef6https://scholars.lib.ntu.edu.tw/handle/123456789/535509[SDGs]SDG2[SDGs]SDG3CD4 antigen; CD69 antigen; AIDS related complex; antigen expression; Cytomegalovirus; high risk patient; highly active antiretroviral therapy; human; immune response; immunity; immunostimulation; infection risk; letter; lymphocyte proliferation; nonhuman; priority journal; retinitis; T lymphocyte; virus reactivation; AIDS-Related Opportunistic Infections; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Cytomegalovirus; Cytomegalovirus Retinitis; HIV Infections; Humans; Immunity; Lymphocyte Activation; Risk FactorsAssociation of cytomegalovirus (CMV)-specific CD4+ T lymphocyte reactivity and protective immunity against acquired immunodeficiency syndrome-related CMV retinitisletter10.1086/34536912447752